Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Affiliations

• ¹ Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
• ² Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
• ³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
• ⁴ Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
• ⁵ Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.
• ⁶ Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
• ⁷ Department of Surgery, Mayo Clinic, Jacksonville, FL, 32224, USA.
• ⁸ Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA.
• ⁹ Affymetrix, now part of Thermo Fisher Scientific, Santa Clara, CA, 95051, USA.
• ¹⁰ Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, 85259, USA.
• ¹¹ Department of Surgery, Mayo Clinic, Scottsdale, AZ, 85259, USA.
• ¹² Department of Radiology, Mayo Clinic, Rochester, MN, 55905, USA.
• ¹³ Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA.
• ¹⁴ Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. [email protected].